跳至主要内容
临床试验/ITMCTR2200006759
ITMCTR2200006759尚未招募未知

Standardized study on the diagnosis and treatment plan of non-alcoholic fatty liver disease treated with the method of clearing phlegm and dampness

onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1.Age 18 to 75 years;
  • 2.Patients who meet the above western medical diagnostic criteria and the wet turbidity internal stop certificate;
  • 3.Patients who are willing to sign informed consent.
  • 4.Serum alanine aminotransferase (ALT) = 2 times the upper limit of normal, total bilirubin (TBIL) = 2 times the upper limit of normal

排除标准

  • 1. Patients with fatty liver, Reye syndrome fatty liver, ß-lipoprotein deficiency and localized fatty liver caused by chronic heart failure, malnutrition and pregnancy. Patients with fatty liver caused by diabetes, long-term use of hormones, small intestinal bypass surgery, toxic injury to liver cells, chronic febrile diseases such as tuberculosis, ulcerative colitis, and chronic infection after gastrointestinal surgery.
  • 2. Severe fatty liver with ascites, edema, hyponatremia, hypokalemia and other suspected manifestations of liver cirrhosis; hepatitis or cirrhosis caused by virus, drug poisoning, immune diseases and other factors.
  • 3. Other Chinese and Western medicines for the treatment of simple fatty liver have been used after this onset.
  • 4. Patients who have serious primary cardiovascular disease, liver disease, kidney disease, hematological disease, lung disease, or serious diseases that affect their survival, such as tumor or AIDS.
  • 5. Mentally or legally disabled patients.
  • 6. Suspected or indeed have a history of alcohol or drug abuse, or other diseases that reduce the possibility of enrollment or complicate enrollment according to the judgment of the investigator, such as frequent changes in the working environment, which are likely to cause loss to follow-up.
  • 7. Those who are known to be allergic to the components of this medicine.

研究者

发起方
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

相似试验

Standardized study on the diagnosis and treatment... | 临床试验